Peptides and oligonucleotides and Pharmaceuticals

Pharmaceuticals depends on peptides and oligonucleotides.

Peptides and oligonucleotides (chemical) and Pharmaceuticals (industry): 1 relationship.

How they are linked

1. Industry input

Physical flow · Criticality 4 of 5 · Peptides and oligonucleotides → Pharmaceuticals

2 of the enterprise types in Pharmaceuticals depend on peptides and oligonucleotides; for the most dependent, it rates 4 out of 5 on criticality.

• 2 enterprise types depend on it
• 4 of 5 highest criticality

Enterprise types that depend on it:

• Innovator pharma and biotech companies: new modalities (criticality 4 of 5)
• Biologics and vaccine manufacturers: peptide and nucleic-acid drugs (criticality 4 of 5)

Built from the site data on production routes, energy flows, industry value chains, input-output tables and prices.